Hyderabad Telangana, India

Kotamraju Srigiridhar

This inventor holds 2 USPTO granted patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kotamraju Srigiridhar. Retrieved from https://idiyas.com/inventor/kotamraju-srigiridhar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kotamraju Srigiridhar

Introduction

Kotamraju Srigiridhar is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of antioxidants and their applications in health. With a total of 2 patents, his work focuses on innovative solutions to combat atherosclerosis.

Latest Patents

His latest patents include an antioxidant compound having an anti-atherosclerotic effect and its preparation. This invention specifically relates to the synthesis of TPP+ coupled esculetin, also known as mitochondria-targeted esculetin (Mito-Esc). The biological evaluation of Mito-Esc demonstrates its ability to attenuate Angiotensin-II-induced atherosclerosis in apolipoprotein E knockout mice, along with the endothelial cell age-delaying effects of Mito-Esc.

Career Highlights

Kotamraju Srigiridhar is associated with the Council of Scientific and Industrial Research, where he continues to advance research in his field. His work has garnered attention for its potential impact on health and disease prevention.

Collaborations

He has collaborated with notable coworkers, including Karnewar Santosh and Vasamsetti Sathish Babu, contributing to a dynamic research environment.

Conclusion

Kotamraju Srigiridhar's innovative work in the field of antioxidants showcases his commitment to advancing health solutions. His contributions are significant in the ongoing fight against atherosclerosis and related health issues.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…